Age-specific reference ranges for serum prostate-specific antigen

Urologic Clinics of North America

Volumn 24, Issue 2, 1997, Pages 339-351

  Richardson, T D ^a   Oesterling, J E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; PROSTATE SPECIFIC ANTIGEN;

AGE; BLOOD LEVEL; CANCER SCREENING; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; REFERENCE VALUE; REVIEW;

EID: 0030973577     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70381-5     Document Type: Article

References (45)

1. J.R. Anderson D. Strickland D. Corbin Age-specific reference ranges for serum prostate-specific antigen Urology 46 1995 54
2. R.J. Babaian C. Mettlin R. Kane The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography Cancer 69 1992 1195
3. R.J. Babaian H. Miyashita R.B. Evans The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: Relationship to gland volume and age J Urol 147 1992 837
4. M.C. Benson I.S. Whang A. Pontuck Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer J Urol 147 1992 815
5. S.J. Berry D.S. Coffey P.C. Walsh The development of human benign prostatic hyperplasia with age J Urol 132 1984 474
6. M.K. Brawer P.H. Lange PSA in the screening, staging, and follow-up of early prostate cancer: A review of recent developments World J Urol 7 1989 7
7. M.K. Brawer E.A.G. Aramburu G.L. Chen The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostate cancer J Urol 150 1993 369
8. M.K. Brawer M.P. Chetner J. Beatie Screening for prostatic carcinoma with prostate specific antigen J Urol 147 1992 841
9. H.B. Carter J.D. Pearson E.J. Metter Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease JAMA 267 1992 2215
10. W.J. Catalona Screening for prostate cancer: Enthusiasm Urology 42 1993 113 115
11. W.J. Catalona M.A. Hudson P.T. Scardino Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: Receiver operating characteristic curves J Urol 152 1994 2037
12. W.J. Catalona D.S. Smith T.L. Ratliff Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1991 1156
13. W.J. Catalona D.S. Smith R.L. Wolfert Evaluation of the percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening JAMA 274 1995 1214
14. G.W. Chodak Questioning the value of screening for prostate cancer in asymptomatic men Urology 42 1993 116
15. A. Christensson C.B. Laurell H. Lilja Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors Eur J Biochem 194 1990 755
16. A. Christensson T. Bjork O. Nilsson Serum prostate-specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer J Urol 150 1993 100
17. G.N. Collins R.J. Lee G.B. McElvie Relationship between prostate specific antigen, prostate volume and age in the benign prostate Br J Urol 71 1993 445
18. W.H. Cooner Definition of the ideal tumor marker Urol Clin North Am 20 1993 575
19. W.H. Cooner B.R. Moseley C.L. Rutherford Prostate cancer detection in a clinical urological practice ultrasonography, digital rectal examination, and prostate specific antigen J Urol 143 1990 1146
20. E.D. Crawford E.P. DeAntoni PSA as a screening test for prostate cancer Urol Clin North Am 20 1993 637
21. B.L. Dalkin F.R. Ahmann J.B. Kopp Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic cancer J Urol 150 1993 1837
22. E.P. DeAntoni E.D. Crawford J.E. Oesterling Age and race-specific reference ranges for prostate-specific antigen from a large community-based study Urology 48 1996 234
23. R.E.S. El-Galley J.A. Petros W.H. Sanders Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma Urology 46 1995 200
24. C.J. Ercole P.H. Lange M. Mathisen Prostate specific antigen and prostatic acid phosphatase in the monitoring and staging of prostate cancer J Urol 138 1987 1181
25. W.J. Glenski R.S. Malek J.F. Myrtle Sustained, substantially increased concentration of prostate-specific antigen in the absence of prostatic malignant disease: An unusual clinical scenario Mayo Clin Proc 67 1992 249
26. M.A. Hudson R.R. Bahnson W.J. Catalona Clinical use of prostate specific antigen in patients with prostate cancer J Urol 142 1989 1011
27. A.A. Luderer Y.T. Chen T.F. Soriano Measurement of the proportion of free to total prostate-specific antigen improves the diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen Urology 46 1995 187
28. T.O. Morgan S.J. Jacobsen W.F. McCarthy Age-specific reference ranges for prostate-specific antigen in African American men N Engl J Med 335 1996 304
29. J.E. Oesterling Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate J Urol 145 1991 907
30. J.E. Oesterling D.W. Chan J.I. Epstein Prostate specific antigen in the preoperative and postoperative evaluation of localized prostate cancer treated with radical prostatectomy J Urol 139 1988 766
31. J.E. Oesterling S.J. Jacobsen W.J. Cooner The use of age-specific reference ranges for serum prostate specific antigen in men 60 years or older J Urol 153 1995 1160
32. J.E. Oesterling W.H. Cooner S.J. Jacobsen Influence of patient age on serum PSA concentration Urol Clin North Am 20 1993 671
33. J.E. Oesterling S.J. Jacobsen C.G. Chute Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges JAMA 270 1993 860
34. J.E. Oesterling S.J. Jacobsen G.G. Klee Free, complexed and total serum prostate specific antigen: The establishment of appropriate reference ranges for their concentration and ratios J Urol 154 1995 1090
35. J.E. Oesterling Y. Kumamoto T. Tsukamoto Serum prostate-specific antigen in a community-based population of healthy Japanese men: Lower values than for similarly aged white men Br J Urol 75 1995 347
36. A.W. Partin J.E. Oesterling The clinical usefulness of prostate specific antigen: Update 1994 J Urol 152 1994 1358
37. A.W. Partin H.B. Carter D.W. Chan Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume, and benign hyperplasia J Urol 143 1990 747
38. A.W. Partin S.R. Criley E.N.P. Subong Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis J Urol 155 1996 1336
39. J.P. Richie W.J. Catalona F.R. Ahmann Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination Urology 42 1993 365
40. J.M. Robles J.R. Morell J.P. Redorta Clinical behavior of prostate specific antigen and prostatic acid phosphatase: A comparative study Eur Urol 14 1988 360
41. P.D. Sershon M.J. Barry J.E. Oesterling Serum PSA values in men with histologically confirmed BPH versus patients with organ-confined prostate cancer [abstract] J Urol 149 1993 421A
42. V.O. Speights P.N. Brawn D.M. Foster Evaluation of age-specific normal ranges for prostate-specific antigen Urology 45 1995 454
43. T.A. Stamey N. Yang A.R. Hay Prostate-specific antigen as a a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909
44. U.H. Stenman J. Leinonen H. Alfthan A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in the serum of patients with prostate cancer Cancer Res 51 1991 222
45. M.C. Wang L.A. Valenzuela G.P. Murphy Purification of a human prostate specific antigen Investig Urol (Berl) 17 1979 159